Longenesis enables efficient participant identification and engagement for clinical studies. Study sponsors can compliantly browse in real-time through more than 1 million patient records from over 30 participating clinics, patient advocacy groups, and biobanks in the EU and MENA, resulting in a 70% reduction in time and cost. Additionally, Longenesis’ “Companion” drives dynamic consent management and instant, on-demand participant engagement for the collection of clinical, real-world evidence and quality of life measures, offering seamless participant management in clinical studies.
Sergey Jakimovs, CEO - email@example.com
Emil Syundyukov, CTO - firstname.lastname@example.org